Helmholtz Gemeinschaft


Targeting the tumor microenvironment of leukemia and lymphoma

Item Type:Review
Title:Targeting the tumor microenvironment of leukemia and lymphoma
Creators Name:Höpken, U.E. and Rehm, A.
Abstract:Despite progress in exploiting therapeutically the genetic vulnerabilities of leukemia and lymphoma, the outcome is often extended progression-free survival but not tumor eradication. Lymphomagenesis is not a tumor-autonomous process, and the onset and progression of tumors requires reciprocal crosstalk with the tumor microenvironment (TME). Minimal residual disease and immunosurveillance are also regulated by factors in the TME. Here, we dissect the stromal compartment in lymphoid organs, focusing on conditions that are prevalent in an autochthonous environment for lymphoid neoplasia. Identification of tumor-promoting factors is instrumental in the selection of therapeutic targets that are part of the immune system. Targeting the TME is an appealing treatment option for lymphoma because this compartment is subject to low selective pressure for mutations.
Keywords:Tumor Microenvironment, Myeloid-Derived Suppressor Cells, Effector Immune Cell Exhaustion, Immune Escape, Adoptive T Cell Therapy, Animals
Source:Trends in Cancer
Publisher:Cell Press
Page Range:351-364
Date:June 2019
Official Publication:https://doi.org/10.1016/j.trecan.2019.05.001
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library